Chemotherapy-Related Tumour Lysis Syndrome
dc.contributor.author | Busakhala, N. W. | |
dc.contributor.other | Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya) | en |
dc.date.accessioned | 2007-11-19T23:01:56Z | |
dc.date.available | 2007-11-19T23:01:56Z | |
dc.date.issued | 2007 | |
dc.description.abstract | Two types of tumour lysis syndrome (TLS) ; 1. Laboratory TLS: 25% increase in potassium, phosphate and uric acid, or decline in calcium from baseline. Occur within 4 days of initiating chemotherapy. Patients on standard of care. Minimum of two out of four criteria. 2. Clinical tumour lysis syndrome: Laboratory TLS plus renal failure, cardiac arrhythmias or sudden death. A new definition has been suggested by Cairo and Bishop to include values above upper limit of normal. Study used Hande and Garrow definition. | en |
dc.identifier.uri | https://hdl.handle.net/1805/1181 | |
dc.language | English | en |
dc.language.iso | en | en |
dc.publisher | Association of Kenya Physicians | en |
dc.subject | tumour lysis syndrome | en |
dc.subject | TLS | en |
dc.subject | renal | en |
dc.subject | cardiac | en |
dc.subject | Hande and Garrow | en |
dc.subject | gout | en |
dc.subject | tumor | en |
dc.subject | hyperkalemia | en |
dc.subject | hyperphosphatemia | en |
dc.subject.lcsh | Chemotherapy | |
dc.subject.mesh | Tumor Lysis Syndrome | |
dc.subject.mesh | Kidney Failure | |
dc.subject.mesh | Drug Therapy | |
dc.subject.mesh | Arrhythmia | |
dc.title | Chemotherapy-Related Tumour Lysis Syndrome | en |
dc.type | Presentation | en |